<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Wisitpongpun P</submitter><funding>Royal Golden Jubilee (RGJ) Ph.D. Programme</funding><pubmed_abstract>Macrophages are a type of innate immune cell that activates the NLRP3 inflammasome, causing the release of the cytokine IL-1β, which is a crucial mediator of the inflammatory response. NLRP3 activation that is dysregulated worsens a variety of inflammatory and autoimmune diseases, as well as neurodegenerative diseases. Oleamide is an endogenous fatty acid amide that was first determined as a sleep-inducing molecule and later shown to have wide-ranging beneficial effects on the central nervous system. How oleamide influences human macrophage polarization and NLRP3-inflammasome activation remains unclear. The effect of oleamide on macrophage polarization was explored using an &lt;i>in vitro&lt;/i> culture of primary human monocyte-derived macrophages (MDMs) supplemented with human serum-containing media. Cellular and molecular mechanisms of oleamide-regulated MDMs polarization were also investigated. Results showed that oleamide promoted naïve macrophages (M0) toward the M1 phenotype by upregulating M1-associated genes (&lt;i>IL-1β&lt;/i>, &lt;i>iNOS&lt;/i>, &lt;i>CXCL10&lt;/i>), along with downregulation of M2-associated genes (&lt;i>Arg-1&lt;/i>, &lt;i>CD206&lt;/i>, &lt;i>CCL22&lt;/i>). Cell surface expression indicated that oleamide enhanced CD80 expression in M0 naïve macrophages and hider CD206 and CD163 expression in M2 macrophages. Higher production of IL-1β cytokine was observed but with no alteration in IL-6 and TNF-α levels by MDMs and differentiated THP-1 models. Whether oleamide functioned as a second signal that activated the NLRP3 inflammasome and mediated IL-1β production was further investigated using LPS-primed MDMs followed by oleamide treatment that induced activation of inflammasome-related proteins including NLRP3, ASC, cleaved casp-1, and cleaved IL-1β. These findings suggested that oleamide promoted M1 macrophage polarization and increased IL-1β production by activating the NLRP3 inflammasome in primary MDMs. This research reveals a new function for oleamide as well as prospective targets for treating NLRP3-related inflammatory disorders.</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>856296</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9062104</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Oleamide-Mediated Polarization of M1 Macrophages and IL-1β Production by Regulating NLRP3-Inflammasome Activation in Primary Human Monocyte-Derived Macrophages.</pubmed_title><pmcid>PMC9062104</pmcid><pubmed_authors>Potup P</pubmed_authors><pubmed_authors>Usuwanthim K</pubmed_authors><pubmed_authors>Wisitpongpun P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oleamide-Mediated Polarization of M1 Macrophages and IL-1β Production by Regulating NLRP3-Inflammasome Activation in Primary Human Monocyte-Derived Macrophages.</name><description>Macrophages are a type of innate immune cell that activates the NLRP3 inflammasome, causing the release of the cytokine IL-1β, which is a crucial mediator of the inflammatory response. NLRP3 activation that is dysregulated worsens a variety of inflammatory and autoimmune diseases, as well as neurodegenerative diseases. Oleamide is an endogenous fatty acid amide that was first determined as a sleep-inducing molecule and later shown to have wide-ranging beneficial effects on the central nervous system. How oleamide influences human macrophage polarization and NLRP3-inflammasome activation remains unclear. The effect of oleamide on macrophage polarization was explored using an &lt;i>in vitro&lt;/i> culture of primary human monocyte-derived macrophages (MDMs) supplemented with human serum-containing media. Cellular and molecular mechanisms of oleamide-regulated MDMs polarization were also investigated. Results showed that oleamide promoted naïve macrophages (M0) toward the M1 phenotype by upregulating M1-associated genes (&lt;i>IL-1β&lt;/i>, &lt;i>iNOS&lt;/i>, &lt;i>CXCL10&lt;/i>), along with downregulation of M2-associated genes (&lt;i>Arg-1&lt;/i>, &lt;i>CD206&lt;/i>, &lt;i>CCL22&lt;/i>). Cell surface expression indicated that oleamide enhanced CD80 expression in M0 naïve macrophages and hider CD206 and CD163 expression in M2 macrophages. Higher production of IL-1β cytokine was observed but with no alteration in IL-6 and TNF-α levels by MDMs and differentiated THP-1 models. Whether oleamide functioned as a second signal that activated the NLRP3 inflammasome and mediated IL-1β production was further investigated using LPS-primed MDMs followed by oleamide treatment that induced activation of inflammasome-related proteins including NLRP3, ASC, cleaved casp-1, and cleaved IL-1β. These findings suggested that oleamide promoted M1 macrophage polarization and increased IL-1β production by activating the NLRP3 inflammasome in primary MDMs. This research reveals a new function for oleamide as well as prospective targets for treating NLRP3-related inflammatory disorders.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T17:49:09.123Z</modification><creation>2025-04-19T17:49:09.123Z</creation></dates><accession>S-EPMC9062104</accession><cross_references><pubmed>35514993</pubmed><doi>10.3389/fimmu.2022.856296</doi></cross_references></HashMap>